Antileishmanial assessment of leaf extracts from Pluchea carolinensis, Pluchea odorata and Pluchea rosea  by García, Marley et al.
836 Asian Pacific Journal of Tropical Medicine (2011)836-840
Document heading          doi:  
Antileishmanial assessment of leaf extracts from Pluchea carolinensis, 
Pluchea odorata and Pluchea rosea
Marley García1, Wilmer H Perera2, Ramón Scull3, Lianet Monzote1*
1Parasitology Department, Institute of Medicine Tropical “Pedro Kourí”, Havana City, Cuba
2Institute of Ecology and Systematic, Havana City, Cuba
3Institute of Pharmacy and Food, Havana City, Cuba
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 12 Apirl 2011
Received in revised form 15 July 2011
Accepted 15 August 2011
Available online 20 October 2011
Keywords:
Pluchea carolinensis
Pluchea odorata
Pluchea rosea
Medicinal plants
Leishmania amazonensis
  *Corresponding author: Lianet Monzote, Departamento de Parasitología, Instituto de 
Medicina Tropical “Pedro Kourí”, Apartado Postal No. 601, Marianao 13. Ciudad de la 
Habana, Cuba.
     Tel: +53-7-202-60-51
     Fax: +53-7-204-6051
     E-mail: beorimadegun@yahoo.com
1. Introduction
  Leishmaniasis is one of the most diverse and complex 
of all vector borne diseases. It is caused by an obligated 
intracellular protozoa parasite belonging to the genus 
Leishmania. The disease affects approximately 12 million 
people from 88 countries, with an increasing incidence of 
1.5-2.0 million new cases diagnosed every year and 350 
million people at risk. It is manifested mainly in three 
clinical forms: cutaneous, mucocutaneous and visceral 
leishmaniasis, from which the visceral disease constitutes 
the fatal form if untreated[1,2].
  In the current scenario, the chemotherapy is one of the 
promising actions to control the disease. Conventional drugs 
have serious limitations such as high cost, toxicity, difficult 
route of administration and lack of efficacy in endemic 
areas. The development of safe, effective and affordable 
antileishmanial agents is a need[3]. In endemic areas, the 
population use plants to treat many infectious diseases, 
including leishmaniasis[4].
  Cuba is well known for rich flora with a high percentage of 
endemic species. It is considered as an interesting source of 
plant species for searching bioactive metabolites. The genus 
Pluchea contains many species with important medicinal 
properties[5]. The genus includes 80 species from which 30-
40 live in tropical regions (6) and only three of them are 
Cuban: Pluchea carolinensis (P. carolinensis)(Jacq.) G. Don., 
Pluchea odorata (P. odorata) (Sw.) DC. and Pluchea rosea 
(P. rosea) Godfrey. The Cuban species of Pluchea are well 
known for their ethnomedical use, including headaches, 
fever and slow digestions. Antimicrobial properties of 
different plant organs of some species of the genus Pluchea 
have been tested against bacterias, fungi and viruses[5,7]. On 
the other hand, some chemical studies have been carried 
out in the genus Pluchea. The most widely distributed 
metabolites are terpenoids followed by flavonoids[5] and 
it’s well known that these kinds of phytochemicals have 
antileishmanial activity[8,9]. The present study is to evaluate 
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the antileishmanial activity of different extracts from three 
Cuban Pluchea species.
2. Materials and methods
2.1. Extracts from P. carolinensis
  Samples of P. carolinensis (HAC 41725) were collected in 
“Sierra del Rosario” (Pinar del Río) in March 2006; while 
P. rosea (LS 16648) and P. odorata (LS 17198) were collected 
in “Ciénaga de Zapata” (Matanzas) in May 2006. The 
blooming specimens were deposited in the HAC herbarium 
of the “Instituto de Ecología y Sistemática” (Havana), 
Cuba. Leaves of plants were extracted at room temperature 
during 3 days. The hydroalcoholic solution (70% ethanol) 
was pooled, evaporated and subjected to liquid–liquid 
extractions with solvents of increasing polarity[10]. One liter 
of the solutions was extracted eight times in a separating 
funnel, firstly with 400 mL of n-hexane and the other times 
with 200 mL each one. The n-hexane solution was pooled, 
filtered and dried at low pressure until n-hexane crude 
extracts was obtained. The same methodology was followed 
up by chloroform, ethyl acetate and n-butyl alcohol. All 
extractions were performed in duplicates. After evaporation, 
dried samples were dissolved in dimethyl sulfoxide (DMSO) 
at 20 mg/mL.
2.2. Parasite culture
  Leishmania amazonensis (L. amazonensis) (MHOM/77BR/
LTB0016) was kindly provided by the Department of 
Immunology, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. 
Parasites were routinely isolated from mouse lesions 
and maintained as promastigotes at 26 ℃ in Schneider’s 
medium (SIGMA, St. Louis, MO, USA) containing 10% heat-
inactivated fetal bovine serum (HFBS) (SIGMA, St. Louis, MO, 
USA), streptomycin 100 毺g/mL, and penicillin 100 U/mL. 
All parasites were not used after the tenth passage.
2.3. Laboratory animals
  Female BALB/c mice, with a body weight of approximately 
20-22 g, were obtained from National Center of Laboratory 
Animals Production (CENPALAB). The maintenance and care 
of mice was followed according to guidelines from Ethics 
Committee for the Human Use of Laboratory Animals. The 
temperature and humidity were controlled, with 12 h light/
dark cycle and given water and food ad libitum for all 
animals.
2.4. Reference drug
  As a drug reference amphotericin B (AmB, IMEFA, Cuba) 
was used at a concentration of 2 mg/mL. The drug was 
diluted in sterile distilled water.
2.5. In vitro evaluations
2.5.1. Antipromastigote assay
  Promastigotes of L. amazonensis (105 promastigotes/mL) 
were distributed in 96-well plates, treated with 1 毺L of 
extracts or DMSO, and then incubated at 26 ℃. After 72 h, 
the parasites were incubated for 3 h with P-nitrophenol 
phosphate (20 mg/mL) dissolved in 1 mol/L sodium acetate 
buffer (BDH, Poole, England), pH 5.5, with 1% Triton 伊
-100 (BDH, Poole, England) at 37 ℃. The absorbance 
was determined in an EMS Reader MF Version 2.4-0, at a 
wavelength of 405 nm[11]. 
2.5.2. Cytotoxicity assay
  Peritoneal macrophages were collected from normal 
BALB/c mice in RPMI 1640 medium (SIGMA, St. Louis, 
Mo, USA) supplemented with antibiotics, and seeded at 
30 000 cell/well. The cells were incubated for 2 h at 37 ℃ 
in 5% CO2 and non-adherent cells were removed. Dilutions 
of the extracts or DMSO were added and incubated in the 
same conditions during 72 h. The viability was determined 
adding 15 毺L of 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) (SIGMA, St. Louis, MO, 
USA) at 5 mg/mL. After incubation for an additional 4 h 
the formazan crystals were dissolved by addition of 100 毺
L DMSO. The optical density was determined using an EMS 
Reader MF Version 2.4-0, at a test wavelength of 560 nm 
and a reference wavelength of 630 nm[12].
2.5.3. Antiamastigote assay
  The peritoneal macrophages monolayer was obtained and 
infected with stationary-phase L. amazonensis promastigotes 
at 4:1 parasite/macrophage ratio and incubated for further 4 h. 
The monolayer’s cell was washed and treated with 1 毺L
of extracts or DMSO for further 48 h. Parasites were then 
fixed, stained with Giemsa, and examined under light 
microscopy[13]. The number of intracellular amastigotes 
and infected macrophage was determined by counting and 
the percent of inhibition were calculated in comparison to 
cultures treated with DMSO[14]. 
  The medium inhibitory concentration (IC50) value and 
medium cytotoxicity concentration (IC50) were determined 
from the lineal concentration-response curves. The 
selectivity index (SI) ratio was calculated trough division of 
IC50 for macrophage by IC50 for promastigotes[15].
2.6. In vivo studies
2.6.1. Infection and treatment
  On day 0, mice were infected with 107 logarithmic 
promastigotes by subcutaneous route in the right footpads. 
On day 15 post-infection (pi.), mice were randomly divided 
into four groups: two control groups (one group treated 
with vehicle and other one untreated), one group treated 
with extract 100 mg/kg, and the last group treated with 
amphotericin B 1 mg/kg. Treatment was administered daily 
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by intraperitoneal route from day 15 pi. to the day 30 pi. 
2.6.2.Biological evaluation
  Animals were checked daily to record the death and the 
individual corporal weigh were determined each 7 days. 
Disease progression was monitored by measuring footpads 
swelling, using an automatic calliper. Average lesion size 
was calculated as the differences obtained between infected 
and uninfected footpads. On day 45 pi., six animals of each 
group were killed by cervical dislocation and the parasite 
burden was determined using the culture microtitration 
method described by Buffet and collaborators[16].
2.7. Statistical analyses
  Data on lesion progression were analyzed for statistical 
significance by the analysis of variance test, following of 
a post hoc test (LDS test or planned comparison) using the 
Statistical for Windows Program (Release 4.5, StatSoft, Inc. 
1993).
3. Results
  The three extracts evaluated inhibited promastigotes form 
growing. P. carolinensis extracts showed the best activity, 
with IC50 values below of 100 毺g/mL from all extracts, 
except for n-butanol extract. The active extracts caused a 
high toxicity; although the ethanol and n-hexane extracts 
demonstrated the more specific antileishmanial activity 
(Table 1). The ethanol and n-hexane extracts from P. 
carolinensis caused similar inhibition against amastigote 
form, which IC50 values of 30.9 毺g/mL and 29.6 毺g/mL, 
respectively. Amphotericin B showed an IC50 of 0.034 毺g/mL.
  The intraperitoneal administration of the ethanol extract of 
P. carolinensis at 100 mg/kg prevented lesion development 
compared with the animals treated with the vehicle, 
untreated mice, as well as mice treated with amphotericin B 
(P<0.05). However, the treatment with n-hexane extract did 
not decrease the lesion size (P>0.05) respecting untreated 
animals. These results were corroborated when the parasite 
burden was determined (Figure 1).
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Figure 1. Effect of the ethanol and n-hexane extracts from Pluchea 
carolinensis extracts (100 mg/kg), Vehicle (0.1 mL) and Amphotericin 
B (1 mg/kg) on lesion growth. BALB/c mice were infected in the 
footpad by subcutaneous infection with 107 promastigotes of L. 
amazonensis and treated by intraperitoneal route during 15 days. 
Lesion sizes were measured at the indicated times post-infection and 
the results are expressed as mean  standard deviation.
Table 1
Activity of Pluchea spp. extracts and amphotericin B on promastigotes of L. amazonensis and macrophage from BALB/c mice.
Plant Specie Extract
IC50
a依SDb (毺g/mL)
SIc
Promastigote Macrophage
P. carolinensis EtOH 30.4依1.2 172.2依1.0 6
CHCl3 61.2依2.4   64.8依1.1 1
n-hexane 54.5依4.8 241.5依1.3 4
EtOAc 90.3依9.1   57.4依2.7 1
n-BuOH > 100 NDd -e
P. odorata CHCl3 > 100 ND -
n-hexane 93.5依7.6 59.7依2.7 0
EtOAc > 100 ND -
n-BuOH > 100 ND -
P. rosea CHCl3 67.9依8.6 80.1依7.4 1
n-hexane > 100 ND -
EtOAc > 100 ND -
n-BuOH > 100 ND -
Amphotericin B 0.026依0.003 5.9依0.5 172
a: IC50: Concentration of drug that caused 50 % of inhibition. b: SD: Standard deviation. c: SI: Selectivity index. d: ND: activity not detected. e: -: 
Not done.
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4. Discussion
  Plant extracts or plants-derived compounds are likely 
to provide a valuable source of new medicinal agents[17,18] 
and the urgent need for alternative treatments has led 
to a program to screen natural products for potential use 
in therapy of leishmaniasis. The leishmanicidal activity 
of several extracts has been evaluated on different plant 
family[19]. Approximately, 20 different species of Asteraceae 
family[4,20,21] have demonstrated to have antileishmanial 
potentialities. Among them, the genus Pluchea has been the 
less explored, but reports shows that some species of the 
genus have been identified as sources of antimicrobial crude 
extracts[5]. In addition, etnobotanical reports have described 
the use of P. carolinensis to treat migraine in Puerto Rico 
population[22] and P. odorata as anticancer in Guatemala[23]. 
Here, we report for the first time the antileishmanial 
evaluation of different extracts from three species of 
Pluchea.
  Different in vitro activities against promastigote form were 
recorded of the extracts, which were prepared using different 
solvents, as well as cytotoxicity effect on macrophage from 
BALB/c mice. The best selectivity was demonstrated by 
ethanol and n-hexane extracts from P. carolinensis, which 
inhibited the growth of intracellular amastigote with an IC50 
value of 30 毺g/mL, approximately. These results led us to 
evaluate both extracts in vivo with the aim to validate the 
antileishmanial potentialities of these plants.
  The leaf ethanol extract from P. carolinensis showed the 
greatest activity in BALB/c mice experimentally infected. In 
addition, no death or weight losses higher than 10% were 
observed in the treated animals with the extract. Toxicity 
of natural products is important because of the interest in 
alternative therapies and the therapeutic use of medicinal 
plants in endemic populations, which should be safe to use. 
One limitation of conventional antileishmanial treatments 
result their side effects. Many people worldwide have no 
access to conventional pharmacological treatments but 
depend on folk remedies. The widespread use of traditional 
medicine suggests that natural products are harmless, but 
their safety require scientific demonstrations[24].
  The amphotericin B showed better activity in vitro 
compared with the extracts evaluated, which are 
complex mixture of substances. The purification of active 
compounds might result in a considerable increase of 
their antileishmanial activity. In addition, amphotericin 
B is a pure compound and constitutes the most active 
antileishmanial drug. Nevertheless, due to their toxicity 
the amphotericin B is considered as a second option in 
areas refractory to antimony[25,26]. In contrast, experiment 
the ethanol extract from P. carolinensis cause higher 
efficacy against cutaneous leishmaniasis in vivo. Previous 
studies have suggested the low effect of amphotericin B 
against leishmaniasis caused by L. amazonensis in BALB/c 
mice[27,28].
  Previously has been demonstrated that among the phenolic 
compounds, flavonoids are constituents from P. carolinensis 
extracts. In deep, aglycone flavonols with kaempferol, 
myricetin and quercetin skeletons were detected from crude 
ethylacetate extract, in (374 依 1), (62 依 3) and (2 622 依 2) 
毺g per gram of leaf dry weight/g, respectively[29]. These 
flavonols have hydroxyl group in the positions 3′ and 4′ of the 
flavan skeleton. In this sense, the 3′,4′,5,6,7-pentahydroxy-
3-methoxyflavone was also identified from leaves of P. 
carolinensis[30]. So, it is possible that these flavonols would 
be responsible in part for the antileishmanial activity 
found for this extract. In addition, some terpenoids with 
skeleton type cuauthemone and eudesmane[31] have been 
isolated from crude leaf extract from the species Pluchea 
carolinensis. This kind of phytochemicals could be also the 
responsible of the antileishmanial activity found in the non-
polar extract.
  The mechanism of action related with antileishmanial 
activity of P. carolinensis has not been studied, although in 
this study we demonstrated their direct effect on Leishmania 
parasites growing. In addition, Rosales et al reported the 
anti-inflamatory effect of P. carolinensis extracts[32], which 
could influence the decreased of lesion growing. During the 
infection by Leishmania parasite occurs an inflammatory 
process in the site of infection due to the influx of cytokines 
and others effectors cells of the immune system, which have 
direct relation with lesion size[11].
  The assessment of different extracts from three Cuban 
species of the genus Pluchea could suggest that P. 
carolinensis is the most promising species among the studied 
and further studies can be performe to evaluate the flavonols 
compounds isolated from this plant as a source of new 
antileishmanial agent.
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